https://transparencyreport.janssen.com/us/us-pharmaceutical-transparency-report https://transparencyreport.janssen.com/us/us-pharmaceutical-transparency-report In 2019, we advanced responsible business practices across a range of topics relating to ethics and transparency (compliance, bioethics, information security and data privacy, and corporate governance) and product quality, safety and reliability (product quality, patient safety, ingredient safety and combating counterfeiting and illicit trade).